MiR-27 as a prognostic marker for breast cancer progression and patient survival.

por Wei Tang, Jiujun Zhu, Shicheng Su, Wei Wu, Qiang Liu, Fengxi Su, Fengyan Yu
Publicado 2012

Markers of tumor-initiating cells predict chemoresistance in breast cancer.

por Chang Gong, Herui Yao, Qiang Liu, Jingqi Chen, Junwei Shi, Fengxi Su, Erwei Song
Publicado 2010

Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1

por Yinghua Zhu, Yujie Liu, Chao Zhang, Junjun Chu, Yanqing Wu, Yudong Li, Jieqiong Liu, Qian Li, Shunying Li, Qianfeng Shi, Liang Jin, Jianli Zhao, Dong Yin, Sol Efroni, Fengxi Su, Herui Yao, Erwei Song, Qiang Liu
Publicado 2018

A serum microRNA signature predicts trastuzumab benefit in HER2-positive metastatic breast cancer patients

por Huiping Li, Jiang Liu, Jianing Chen, Huiyun Wang, Linbin Yang, Fei Chen, Siting Fan, Jing Wang, Bin Shao, Dong Yin, Musheng Zeng, Mengfeng Li, Jun Li, Fengxi Su, Qiang Liu, Herui Yao, Shicheng Su, Erwei Song
Publicado 2018